Evidence map›Paper›PMID 30460740›Full record

ArticleInternational wound journal2019

Using a muscle pump activator device to stimulate healing for non-healing lower leg wounds in long-term care residents.

Connie Harris, Dorace Ramage, Azi Boloorchi, Lisa Vaughan, Gabriella Kuilder, Sally Rakas

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in International wound journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04700735 completednot on this mapstarted 2021, after this paper: background citation

Cross Therapy Registry - Edema Post Market Clinical Follow-up of Safety and Patient Outcomes for Subjects Undergoing Peroneal Nerve Stimulation by Geko™.

Typeobservational_patient_registrySponsorFirstkind LtdRan2021 to 2023Enrolled83ConditionsEdema LegArmsgeko Neuromuscular Electro Stimulator (NMES)
NCT04704557 terminatednot on this mapstarted 2021, after this paper: background citation

Cross Therapy Registry - Oedema Post Market Clinical Follow-up of Safety and Patient Outcomes for Subjects Undergoing Peroneal Nerve Stimulation by Geko™. CTR-Oedema-EU

Typeobservational_patient_registrySponsorFirstkind LtdRan2021 to 2021Enrolled35ConditionsEdema LegArmsgeko Neuromuscular Electro Stimulator (NMES)
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Connie HarrisPerfuse Medtec Inc., London, Ontario, Canada.ORCID https://orcid.org/0000-0002-6775-1031
Dorace RamagePerfuse Medtec Inc., London, Ontario, Canada.
Azi BoloorchiRevera, Mississauga, Ontario, Canada.
Lisa VaughanRevera, Mississauga, Ontario, Canada.
Gabriella KuilderRevera, Mississauga, Ontario, Canada.
Sally RakasRevera, Mississauga, Ontario, Canada.
Canadian Standards Association · CALittelfuse (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic non-healing wounds are a burden in the Long-Term Care (LTC) sector, increasing costs, morbidity, and mortality and causing pain and suffering. The objective of this LTC Innovation pilot was to test the value of a promising new neuromuscular stimulation device in elevating the experience and satisfaction of the residents, engaging and empowering the nursing staff, and improving healing and/or reducing costs. Small, wireless, and worn at the knee, this muscle pump activator is self-contained, wearable, and battery-powered to increase lower-leg blood circulation (up to 60% of that achieved by walking). It has no wires, weighs just 10 g, and is easy to use. Nurses in four LTC homes identified residents with non-healing lower leg wounds. Consent was obtained, and on-site training was delivered. Eleven residents were recruited. Only seven met the inclusion criteria for venous/mixed or diabetic foot ulcers. Of the seven who met the criteria and were adherent with best practices and the muscle pump activator, four healed 100%, and one healed 90%. Two patients with other aetiologies, who were also adherent, healed. All adherent residents had an average weekly decrease in wound size of 9.75% and were extremely happy with the results. Three residents who were non-adherent had a 9.25% increase in wound size per week. One patient with diabetic foot ulcers developed skin changes at the end of life and passed away. Nursing staff and cognisant residents can easily adjust the pulse of muscle pump activator, and application and removal are simple. Most residents feel engaged with the therapy "because they feel it working". The LTC corporation feels that it is a great adjunctive solution for many types of lower-leg wounds (venous, mixed, diabetic, pressure) in addition to best practices in the LTC and Retirement home sectors.

Indexed as

AdultAgedAged, 80 and overAssisted CirculationBlood Flow VelocityChronic DiseaseDiabetic FootElectric Stimulation TherapyFemaleHomes for the AgedHumansLong-Term CareMaleMiddle AgedNursing HomesPilot Projectsblood flowgekolong-term caremuscle pump activatorwounds

Identifiers

PMID30460740
PMCPMC7379663
OpenAlexW2901494294

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.